Chemours [CC] vs Linde plc [LIN] Detailed Stock Comparison

Chemours

NYSE
Loading...

Linde plc

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Chemours wins in 5 metrics, Linde plc wins in 15 metrics, with 0 ties. Linde plc appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricChemoursLinde plcBetter
P/E Ratio (TTM)67.8334.37Linde plc
Price-to-Book Ratio10.195.86Linde plc
Debt-to-Equity Ratio1,845.6160.56Linde plc
PEG Ratio-0.1127.90Chemours
EV/EBITDA9.5318.94Chemours
Profit Margin (TTM)-7.04%20.02%Linde plc
Operating Margin (TTM)4.46%28.29%Linde plc
EBITDA Margin (TTM)4.46%28.29%Linde plc
Return on Equity-85.27%17.01%Linde plc
Return on Assets (TTM)2.98%6.96%Linde plc
Free Cash Flow (TTM)$-993.00M$4.93BLinde plc
Dividend Yield6.82%1.58%Chemours
1-Year Return-22.47%-1.16%Linde plc
Price-to-Sales Ratio (TTM)0.416.74Chemours
Enterprise Value$6.33B$242.90BLinde plc
EV/Revenue Ratio1.087.36Chemours
Gross Profit Margin (TTM)17.21%48.75%Linde plc
Revenue per Share (TTM)$39$69Linde plc
Earnings per Share (Diluted)$-2.74$13.76Linde plc
Beta (Stock Volatility)1.630.97Linde plc
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Chemours vs Linde plc Stock Performance Analysis

Loading Price Chart...

Chemours
Linde plc
Chemours Stock Overview | Linde plc Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Chemours-2.05%1.28%-2.77%27.21%50.05%-5.45%
Linde plc0.39%-1.67%-1.28%-0.22%10.02%13.13%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Chemours-22.47%-40.13%-31.48%147.26%-24.22%-24.22%
Linde plc-1.16%70.17%101.03%328.17%416.54%906.98%

News Based Sentiment: Chemours vs Linde plc

Chemours

News based Sentiment: MIXED

October brought a flurry of analyst activity – both positive and negative – alongside a slight dip in the stock price. The upcoming earnings report on November 3rd will be a critical catalyst, making this a significant month for Chemours investors. The conflicting signals create a nuanced investment picture.

View Chemours News Sentiment Analysis

Linde plc

News based Sentiment: POSITIVE

Linde is experiencing a mix of positive developments – strong institutional investment, positive analyst ratings, and a bullish technical signal – balanced against a high valuation. The upcoming earnings release will be crucial in determining whether the company can justify its premium price and maintain its growth trajectory.

View Linde plc News Sentiment Analysis

Performance & Financial Health Analysis: Chemours vs Linde plc

MetricCCLIN
Market Information
Market Cap i$2.42B$222.60B
Market Cap CategoryMid capMega cap
10 Day Avg. Volume i2,693,8601,460,950
90 Day Avg. Volume i2,984,2901,675,487
Last Close$15.80$468.55
52 Week Range$9.13 - $22.38$408.65 - $487.49
% from 52W High-29.40%-3.89%
All-Time High$58.08 (Oct 23, 2017)$487.49 (Oct 14, 2024)
% from All-Time High-72.80%-3.89%
Growth Metrics
Quarterly Revenue Growth0.04%0.00%
Quarterly Earnings Growth0.05%0.03%
Financial Health
Profit Margin (TTM) i-0.07%0.20%
Operating Margin (TTM) i0.04%0.28%
Return on Equity (TTM) i-0.85%0.17%
Debt to Equity (MRQ) i1,845.6160.56
Cash & Liquidity
Book Value per Share (MRQ)$1.58$80.70
Cash per Share (MRQ)$3.35$11.23
Operating Cash Flow (TTM) i$258.00M$9.63B
Levered Free Cash Flow (TTM) i$99.25M$3.41B
Dividends
Last 12-Month Dividend Yield i6.82%1.58%
Last 12-Month Dividend i$0.75$7.28

Valuation & Enterprise Metrics Analysis: Chemours vs Linde plc

MetricCCLIN
Price Ratios
P/E Ratio (TTM) i67.8334.37
Forward P/E i6.9827.90
PEG Ratio i-0.1127.90
Price to Sales (TTM) i0.416.74
Price to Book (MRQ) i10.195.86
Market Capitalization
Market Capitalization i$2.42B$222.60B
Enterprise Value i$6.33B$242.90B
Enterprise Value Metrics
Enterprise to Revenue i1.087.36
Enterprise to EBITDA i9.5318.94
Risk & Other Metrics
Beta i1.630.97
Book Value per Share (MRQ) i$1.58$80.70

Financial Statements Comparison: Chemours vs Linde plc

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)CCLIN
Revenue/Sales i$1.37B$8.11B
Cost of Goods Sold i$1.13B$4.16B
Gross Profit i$236.00M$3.96B
Research & Development i$27.00M$38.00M
Operating Income (EBIT) i$78.00M$2.22B
EBITDA i$181.00M$3.15B
Pre-Tax Income i$0$2.18B
Income Tax i$4.00M$511.00M
Net Income (Profit) i$-4.00M$1.71B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)CCLIN
Cash & Equivalents i$464.00M$5.29B
Total Current Assets i$2.93B$13.60B
Total Current Liabilities i$1.67B$14.49B
Long-Term Debt i$4.28B$17.61B
Total Shareholders Equity i$580.00M$39.46B
Retained Earnings i$1.66B$13.55B
Property, Plant & Equipment i$8.30BN/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)CCLIN
Operating Cash Flow i$-104.00M$2.34B
Capital Expenditures i$-84.00MN/A
Free Cash Flow i$-196.00M$891.00M
Debt Repayment i$-46.00M$-1.01B
Common Stock Repurchase iN/A$-1.11B

Short Interest & Institutional Ownership Analysis

MetricCCLIN
Shares Short i13.67M5.14M
Short Ratio i4.342.93
Short % of Float i0.13%0.01%
Average Daily Volume (10 Day) i2,693,8601,460,950
Average Daily Volume (90 Day) i2,984,2901,675,487
Shares Outstanding i149.43M473.24M
Float Shares i141.50M469.47M
% Held by Insiders i0.00%0.00%
% Held by Institutions i1.01%0.88%

Dividend Analysis & Yield Comparison: Chemours vs Linde plc

MetricCCLIN
Last 12-Month Dividend i$0.75$7.28
Last 12-Month Dividend Yield i6.82%1.58%
3-Year Avg Annual Dividend i$0.83$5.83
3-Year Avg Dividend Yield i1.03%0.34%
3-Year Total Dividends i$2.50$17.48
Ex-Dividend DateFeb 28, 2025Sep 04, 2025